Monthly Dosing Slightly Edges Out As-Needed Protocol, 2-Year CATT Results Find

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Monday, May 7, 2012

Ocular Surgery News

Monthly dosing with either bevacizumab or ranibizumab yielded slightly better visual acuity than as-needed dosing, with a 2.4 letter difference, a speaker said here regarding the 2-year results of the CATT.

Full Story

The most likely cause of the pigmentation depicted in this image is:
1. melanin
2. iron
3. silver
4. carbon
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
CareCloud Central
CareCloud Central is a medical practice ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Monthly Dosing Slightly Edges Out As-Needed Protocol, 2-Year CATT Results Find

Comments

Quick Quiz

The most likely cause of the pigmentation depicted in this image is:

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

CareCloud Central

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2